Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 13, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 16
- −1 vs. Q4 2025
- Portfolio value
- $652.4M
- +$97.3M (+17.5%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $258.1M | 39.6% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 5,623,816 | $173.6M | 26.6% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $57.5M | 8.8% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 1,784,517 | $55.8M | 8.6% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 4,024,861 | $38.1M | 5.8% | 00.0% | Unchanged | History |
| CTNMContineum Therapeutics, Inc. | CL A | 1,979,173 | $25.8M | 4.0% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 814,586 | $14.7M | 2.3% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $9.02M | 1.4% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $8.95M | 1.4% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $4.05M | 0.6% | 00.0% | Unchanged | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,849,445 | $3.61M | 0.6% | 00.0% | Unchanged | History |
| RLYBRallybio Corp | COM | 152,901 | $1.37M | 0.2% | −301,644−66.4% | ReducedConverted for a 1-for-8 split | History |
| VORVor Biopharma Inc. | COM NEW | 53,732 | $958.6K | 0.1% | 00.0% | Unchanged | History |
| LABStandard Biotools Inc. | COM | 311,967 | $286.8K | <0.1% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 83,554 | $189.7K | <0.1% | −75,298−47.4% | Reduced | History |
| ACETAdicet Bio, Inc. | COM NEW | 22,779 | $155.1K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2025 (1)
Positions held at the end of Q4 2025 that are gone from this filing.